scorecardresearch
Add as a preferred source on Google
Wednesday, April 1, 2026
HomeHealth

Health

MIT study answers why some cancer treatments fail. Most tumours have active backdoor pathways

Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.

In a small town in Gujarat, researchers are training AI to detect anaemia, without drawing blood

Innovation one of 33 shortlisted from over 150 applications got under ICMR-NIN INFUSE initiative. Study protocol published preprint last April, intended product is a smartphone app.

A 5-spice mix to fight long-term diabetes & obesity complications? ICMR set to back human trials

Looking beyond blood sugar control, ICMR-NIN scientists have combined 5 regular kitchen spices in precise proportions, 'marking a shift toward integrative health solutions'.

As GLP-1 generics flood Indian market, drug regulator cracks down on illegal sale & misleading ads

The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.

NEET-PG cut-off reduction didn’t alter merit, only expanded pool—Centre reiterates stand in SC

The affidavit is the government's third submission to the SC in response to a writ petition filed by social worker Harisharan Devgan & others challenging the January cut-off revision.

‘Price no challenge, mindset is’: Novo Nordisk eyes next-gen anti-obesity drugs as generics enter market

Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.

Yes or no to front-of-pack warning labels? Industry, consumer groups dig their heels in at FSSAI meet

Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.

Why do women make up two-thirds of Alzheimer’s cases? Study links risk to hormonal changes in midlife

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.

FSSAI seeks more time from SC to work on front-of-pack labels for foods with high fat, sugar & salt

Food regulator FSSAI weighs pictures versus labels on packaged food amid growing pressure for long-overdue health reform.

Why new guidelines in US recommend screening for ‘bad cholesterol’ as early as ages 9-11

Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.

On Camera

The 3 M’s Of Hinduphobia: Mill, Macaulay and Marx

Indians tend to fuss more about the damage done to the Indian psyche by Thomas B Macaulay’s infamous Minute of 1835, but he was preceded in this unholy endeavour by James Mill.

Indian bonds under pressure as RBI forex curbs raise rate hike risk

The RBI’s crackdown on bearish rupee positions may be followed by additional measures, including tighter limits on banks’ positions and further curbs in the offshore currency market, according to Barclays.

More ‘hits’ than Rheinmetall ever—Ukraine drone manufacturer claps back at CEO’s ‘housewives’ remark

Oleksandr Yakovenko, founder of Ukrainian drone maker TAF Industries, further went on to highlight the growing 'irrelevance' of European defence platforms.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.